log
My
Contact
>
Products
>
>
>
Flamma® Fluors Amine
>
Flamma® 552 Amine
- Flamma® Fluors NHS ester
- Flamma® Fluors Sulfo-NHS ester
- Flamma® Fluors Vinylsulfone
- Flamma® Fluors Isothiocyanate
- Flamma® Fluors Maleimide
- Flamma® Fluors Hydrazide
- Flamma® Fluors Dichlorotriazine
- Flamma® Fluors Carboxylic acid
- Flamma® Fluors Amine
- Flamma® Fluors Thiol
- Flamma® Fluors Alkyne
- Flamma® Fluors PEG4-Alkyne
- Flamma® Fluors ADIBO
- Flamma® Fluors Azide
Flamma® 552 Amine
Catalog No. PWE1122
| PACKING UNIT | price |
Lead time |
|---|---|---|
| 1 mg | $121.00 | |
| 5 mg | $420.00 | |
| 25 mg | $840.00 |
Description
Flamma® Fluors 552 Amine is inactive form of bright yellow fluorescent dye induced from cyanine structure and used to generate a stable fluorescence signal in bioimaging. The primary amine is attached to Flamma 552 through a spacer. The maxima of Ex/Em values are at 550/565 nm, similar to that of Alexa 555, DyLight 549, ATTO 550 and Cy3. Flamma 552 might be excited using 532, 543, 546 or 555 nm laser lines and displays excellent optical property. Flamma® Fluors 552 amine can be coupled with carboxylic acids at small molecules or on biomolecules by standard amide bond coupling conditions or can be utilized as a reference standard for dye-conjugates.
Citation & Reference
1. Kim S, Injectable immunogel based on polymerized phenylboronic acid and Mannan for Cancer Immunotherapy. Journal of Controlled Release. 2022 May;345:138–46.
2. Kang B-Y, Phenylboronic acid conjugated to doxorubicin nanocomplexes as an anti-cancer drug delivery system in hepatocellular carcinoma. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 Jun;34:102389.
3. Kim H, Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of covid-19-associated cytokine storm. Nano Today. 2021 Jun;38:101149.
4. Lim J, Phenylboronic-acid-based nanocomplex as a feasible delivery platform of immune checkpoint inhibitor for potent cancer immunotherapy. Journal of Controlled Release. 2021 Feb;330:1168–77.
5. Kim J, Direct fabrication of freestanding and patterned nanoporous junctions in a 3D micro‐nanofluidic device for Ion‐Selective Transport. Small. 2020 Apr 29;16(22).
6. Kim J, Polymer/aptamer-integrated gold nanoconstruct suppresses the inflammatory process by scavenging ROS and capturing pro-inflammatory cytokine TNF-α. ACS Applied Materials & Interfaces. 2020 Nov 6;13(8):9390–401.
7. Jung S, Polymeric nanoparticles controlled by on‐chip self‐assembly enhance cancer treatment effectiveness. Advanced Healthcare Materials. 2020 Oct 18;9(22).
8. Kim J, Direct fabrication of freestanding and patterned nanoporous junctions in a 3D micro‐nanofluidic device for Ion‐Selective Transport. Small. 2020 Apr 29;16(22).
9. Lee SY, Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma. Biomaterials Science. 2019;7(11):4624–35.
10. Son S, Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration. Acta Biomaterialia. 2018 Oct;79:294–305.
11. Kim E, Rapid and versatile cell aggregate formation using lipid-conjugated heparin. ACS Applied Materials & Interfaces. 2018 Jun 28;10(29):24431–9.
12. Jeong JY, Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Acta Biomaterialia. 2017 Apr;53:414–26.
13. Yhee, Ji Young. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance. Journal of Controlled Release 198 (2015): 1-9.
14. Oh, Keun Sang. Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate system. International journal of nanomedicine 9 (2014): 2955.
15. Yoon, Hong Yeol. Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA. Scientific reports 4 (2014).
16. Hollis, Christin P. In vivo investigation of hybrid paclitaxel nanocrystals with dual fluorescent probes for cancer theranostics. Pharmaceutical research 31.6 (2014): 1450-1459.
17. Yhee, Ji Young. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice. Bioconjugate chemistry 24.11 (2013): 1850-1860.
18. Yoon, Hong Yeol. Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting. Journal of Controlled Release 172.3 (2013): 653-661.
19. Park, Jin Woo. Wide-Ranged Fluorescent Molecular Weight Size Markers for Electrophoresis. Bulletin of the Korean Chemical Society 34.1 (2013): 29-30.
20. Koo, Heebeom. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Biomaterials 33.12 (2012): 3485-3493.
21. Zhu, Lei. Real-time monitoring of caspase cascade activation in living cells. Journal of controlled release 163.1 (2012): 55-62.
22. Huang, Xinglu. Multiplex Imaging of an Intracellular Proteolytic Cascade by using a Broad?Spectrum Nanoquencher. Angewandte Chemie International Edition 51.7 (2012): 1625-1630.
23. Ryu, Ju Hee. Early diagnosis of arthritis in mice with collagen?induced arthritis, using a fluorogenic matrix metalloproteinase 3–specific polymeric probe. Arthritis & Rheumatism 63.12 (2011): 3824-3832.
24. Ibrahim, Basma M. A strategy to deliver genes to cystic fibrosis lungs: a battle with environment. Journal of controlled release 155.2 (2011): 289-295.
25. Xu, Peisheng. Zwitterionic chitosan derivatives for pH-sensitive stealth coating. Biomacromolecules 11.9 (2010): 2352-2358.
OPTION
Total
$0
Related Products
1/7
Added cart
We put the items
in the shopping cart.
